Page last updated: 2024-08-21

2-pyrrolidone and Delayed Effects, Prenatal Exposure

2-pyrrolidone has been researched along with Delayed Effects, Prenatal Exposure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bialer, M; Finnell, RH; Isoherranen, N; Merriweather, M; Roeder, M; Schurig, V; Spiegelstein, O; Triplett, AA; Yagen, B; Zhang, J	1

Other Studies

1 other study(ies) available for 2-pyrrolidone and Delayed Effects, Prenatal Exposure

Article	Year
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity. Epilepsia, 2003, Volume: 44, Issue:10 Topics: Animals; Butyrates; Disease Models, Animal; Female; Fetus; Levetiracetam; Mice; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Pyrrolidines; Pyrrolidinones; Teratogens	2003

Article

Year

Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity.

Epilepsia, 2003, Volume: 44, Issue:10

Topics: Animals; Butyrates; Disease Models, Animal; Female; Fetus; Levetiracetam; Mice; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Pyrrolidines; Pyrrolidinones; Teratogens

2003